金吾财讯 | 葛兰素史克(GSK)跌超2%，截至发稿，报39.27美元。消息面上，葛兰素史克周三宣布，同意支付高达22亿美元，以解决美国州法院提起的大多数诉讼，这些诉讼指控一种已停产的胃灼热药物Zantac会导致癌症。该公司与10家原告律师事务所达成的协议解决了约8万起案件，占美国全国州法院针对该公司未决案件的93%。葛兰素史克还表示，将支付7000万美元，以了结康涅狄格州一家实验室提起的举报人诉讼。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.